Skip to content

Aptamer Group

Speeding the time-to-clinic with Optimer®

New research shows how Optimer can speed projects by up to 75% compared to standard antibodies. Speeding project timelines can be vital to the development of any life science product. Whether…

Aptamer intellectual property and licensing

Aptamers function as chemical antibodies across a range of applications. From quality control reagents to point-of-care diagnostics and clinically relevant therapeutics, regardless of the end-use of the developed reagent,…